Source: Annual Congress 2011 - Novel clinical features of acute and chronic lung diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kiyan, G. Okumus, G. Kuran, B. Pamukcu, H. Göksoy, A. Kiyan, S. Yavuz, Z. Bugra, O. Arseven (Istanbul, Bolu, Turkey). Prevalance of pulmonary hypertension in chronic myeloproliferative diseases. Eur Respir J 2011; 38: Suppl. 55, 2983

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in patients with chronic myeloproliferative disorders Source: Eur Respir Rev 2015; 24: 400-410 Year: 2015 Pulmonary hypertension in patients with chronic myeloproliferative disorders Source: Eur Respir J 2010; 35: 1396-1406 Year: 2010 Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Pulmonary veno-occlusive disease in myeloproliferative disorder Source: Eur Respir J 2009; 33: 213-216 Year: 2009 Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 453s Year: 2006 Prevalence of chronic obstructive pulmonary diseases related-hospitalization with acute exacerbation and its associated factors in Thailand. Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 Prevalence of comorbidity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 Metabolic syndrome in chronic obstructive pulmonary disease Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Anemia in chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease Source: Eur Respir J, 50 (2) 1602470; 10.1183/13993003.02470-2016 Year: 2017 Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases Source: Eur Respir Monogr 2020; 88: 167-183 Year: 2020 Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Pulmonary hypertension associated with myeloproliferative disorders suggesting pulmonary veno-occlusive disease: a retrospective study of six cases Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Sleep disorders in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Prevalence and associated factors of osteoporosis among patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010